A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With Asthma
Clinical trial NCT01978119 · COMPLETED
Trial details
- NCT number
- NCT01978119
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-06
- Primary completion
- 2015-01-28
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.